Safety of IPA-containing painkillers should be clarified, KFDA says

Published: 2011-01-14 07:00:00

Updated: 2011-01-14 07:00:00

The Korea Food and Drug Administration has ordered pharmaceutical firms, including Samjin Pharma and Bayer Korea, to conduct a joint research to investigate the safety of isopropylantipyrine (IPA) over side effects such as aplastic anemia until March 2012, as part of its efforts to further streng...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK